Member Exclusive NEWS ROUND-UP

Cell therapy weekly: Celyad to develop next-generation allogeneic CAR-T therapies

This week in cell therapy: Rare mechanism for cancer relapse after CAR-T reported, first results from Avrobio's Fabry disease gene therapy trial and development of a novel technique to generate OPCs.

Go to the profile of RegMedNet
Oct 04, 2018
0
0

Please sign in or register for FREE

No comments yet.